GW Pharmaceuticals Announces Allowance of 5 new Epidiolex Patents
GW Pharmaceuticals is a biopharmaceutical company focused to discover therapeutics from cannabinoids and effectively cover a range of diseases.
The main focus on the company is their seizure treatment product known as Epidiolex. The Food and Drug Administration (FDA) set a Prescription Drug User Free Act (PUFDA) date on June 27th, 2018.
GW Pharmaceuticals announced on March 13th that the company has a receipt of Notices of Allowances on five new Epidiolex patents. These new patents, if the NDA is approved, will expire in 2035. The patents are possibly eligible for additional years with patent adjustments and/or exclusives within regulations.
These patent applications will be listed in the Approved Drug Products with Therapeutic Equivalence Evaluations (ADPTEE) when the NDA for Epidiolex gets approval.
Epidiolex will also receive New Chemical entity exclusivity status as the FDA has given Orphan Drug Designation for the use of Epidiolex to treat seizures associated with several illnesses and diseases.
The patent news for GW Pharmaceuticals brought the stock to the highest price of the month at $122.64 on March 14th. The stock currently trades, after market close on the 15th, at a 2.67% decrease in value.
GW Pharmaceuticals Announces Allowance of 5 new Epidiolex Patents
Cannin Investment Group: Your Hemp Stocks Experts
Cannin.com is your trusted resource for hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2020.
Use Cannin as your resource for:
- Cannabis and hemp stocks & investing news
- Featured cannabis & hemp stocks analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in hemp stocks? No! This is the perfect time to invest.
Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now.
Are you interested in hemp stocks like GW Pharmaceuticals, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Are you looking to buy stock in hemp companies or marijuana companies in 2020? Interested in emerging penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks to invest in? We can help.
Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best hemp stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In
